Alkermes
ALKS
#3099
Rank
NZ$8.74 B
Marketcap
NZ$52.99
Share price
4.43%
Change (1 day)
4.74%
Change (1 year)

Earnings for Alkermes (ALKS)

Earnings in 2025 (TTM): NZ$0.70 Billion

According to Alkermes's latest financial reports the company's current earnings are NZ$1.52 Billion. In 2024 the company made an earning of NZ$0.81 Billion a decrease over its 2023 earnings that were of NZ$0.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alkermes from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.70 B-13.72%
2024 NZ$0.81 B-17.97%
2023 NZ$0.98 B-468.52%
2022 -NZ$0.27 Billion449.24%
2021 -NZ$48.9 Million-68.04%
2020 -NZ$0.16 Billion-52.1%
2019 -NZ$0.32 Billion64.49%
2018 -NZ$0.2 Billion-15.04%
2017 -NZ$0.23 Billion-34.2%
2016 -NZ$0.35 Billion-5.34%
2015 -NZ$0.37 Billion35084.97%
2014 -NZ$1.05 Million
2012 NZ$12.92 M-117.81%
2011 -NZ$72.56 Million-12.69%
2010 -NZ$83.1 Million94.3%
2009 -NZ$42.77 Million-117.7%
2008 NZ$0.24 B622.63%
2007 NZ$33.43 M
2004 -NZ$0.14 Billion-14.48%
2003 -NZ$0.16 Billion11.88%
2002 -NZ$0.14 Billion39.65%
2001 -NZ$98.98 Million5.73%
2000 -NZ$93.61 Million-28.91%
1999 -NZ$0.14 Billion237.28%
1998 -NZ$39.04 Million100.05%
1997 -NZ$19.52 Million-37.93%
1996 -NZ$31.44 Million82.72%
1995 -NZ$17.21 Million-26.79%
1994 -NZ$23.5 Million-72.78%
1993 -NZ$86.34 Million208.07%
1992 -NZ$28.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Acorda Therapeutics
ACOR
-NZ$0.48 Billion-167.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.98 B 1,880.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$56.39 B 7,886.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$20.63 B 2,822.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$22.78 B 3,127.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$3.08 B 336.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
-NZ$0.37 Billion-152.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$15.84 B 2,143.60%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
NZ$28.58 B 3,947.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland